| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 87 |
| 1 | PREDNISONE | 48 |
| 2 | CYCLOPHOSPHAMIDE | 32 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 5 | METHOTREXATE | 30 |
| 6 | METHOTREXATE SODIUM | 30 |
| 7 | DOXORUBICIN | 27 |
| 8 | PREDNISOLONE | 21 |
| 9 | PREDNISOLONE ORAL | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOPHEDIANOL HYDROCHLORIDE, DEXCHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.1250 |
| 1 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 10 | 0.0012 |
| 3 | BENDAMUSTINE HCL | 13 | 0.0008 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | BARICITINIB | 2 | 0.0007 |
| 6 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 7 | RITUXIMAB | 87 | 0.0004 |
| 8 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 9 | GLYCOPYRROLATE | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 3 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 93 | 0.0003 |
| 7 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 3 | 0.0002 |
| 9 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 6 | 0.0002 |